| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/04/1998 | US5788964 Method for sensitization of cancer cells for killer cell mediated lysis |
| 08/04/1998 | US5788963 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 08/04/1998 | CA2149242C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 08/03/1998 | CA2220852A1 Tumor necrosis related receptor, tr4 |
| 08/01/1998 | CA2228385A1 Compounds analogous to thalidomide from the class comprising piperdine-2,6-diones |
| 07/30/1998 | WO1998032866A1 Fusion proteins for intracellular and intercellular transport and their uses |
| 07/30/1998 | WO1998032769A1 Antigen |
| 07/30/1998 | WO1998032748A1 Sulfamide-metalloprotease inhibitors |
| 07/30/1998 | WO1998032733A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 07/30/1998 | WO1998032732A1 5-aroylnaphthalene derivatives |
| 07/30/1998 | WO1998032462A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 07/30/1998 | WO1998032454A1 Centipeda plant extract |
| 07/30/1998 | WO1998032451A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/30/1998 | WO1998032442A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids |
| 07/30/1998 | WO1998024780A3 Substituted pyrimidinone and pyridinone compounds and their use |
| 07/30/1998 | WO1998017313A3 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 07/30/1998 | WO1998010787A3 Pharmaceutical compositions for the treatment of immune disorders |
| 07/30/1998 | DE19803003A1 5-Aroylnaphthalinderivate 5-Aroylnaphthalinderivate |
| 07/30/1998 | DE19802350A1 Sulfamid-Metalloprotease-Inhibitoren Sulfamide metalloprotease inhibitors |
| 07/30/1998 | DE19703131A1 Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen Use of quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as drugs for the treatment of AIDS and / or HIV infection |
| 07/30/1998 | CA2278773A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids |
| 07/30/1998 | CA2278594A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 07/30/1998 | CA2278152A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/30/1998 | CA2278002A1 Fusion proteins for intracellular and intercellular transport and their uses |
| 07/30/1998 | CA2228205A1 Mixtures of outer membranes and/or cell walls of bacteria for oral immunization against mucosal infections |
| 07/30/1998 | CA2228017A1 A drug preparation for oral administration |
| 07/29/1998 | EP0855443A2 cDNA clone HE8CH90 that encodes a 7-transmembrane receptor |
| 07/29/1998 | EP0855402A1 Novel terpenoid compound 0406TP-1 |
| 07/29/1998 | EP0855389A2 A 3,7-dithiaprostanoic acid derivative |
| 07/29/1998 | EP0855184A1 Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination |
| 07/29/1998 | EP0855181A2 Medicament or nutritional formulation for immune-modulation with amino acids |
| 07/29/1998 | EP0854914A1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 07/29/1998 | EP0854885A1 Recombinant anti-cd4 antibodies for human therapy |
| 07/29/1998 | EP0854874A1 Macrocyclic lactone compounds and their production process |
| 07/29/1998 | EP0854870A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 07/29/1998 | EP0854868A1 Substituted hydroisoquinoline derivatives and their use as pharmaceuticals |
| 07/29/1998 | EP0854863A1 Esters and amides as pla2 inhibitors |
| 07/29/1998 | EP0854729A1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 07/29/1998 | EP0854722A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 07/29/1998 | EP0854711A1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 07/29/1998 | EP0854710A2 USE OF A $g(g)-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 07/29/1998 | EP0749428B1 Isoxazoline compounds as inhibitors of tnf release |
| 07/29/1998 | EP0740668B1 Tetracyclic derivatives, process of preparation and use |
| 07/29/1998 | EP0625990B1 Glycoprotein complexes and glycoproteins |
| 07/29/1998 | CN1189166A Somatostatin peptides |
| 07/29/1998 | CN1189151A 维生素d类似物 Vitamin d analogues |
| 07/29/1998 | CN1189105A Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagenosis |
| 07/29/1998 | CN1039329C Process for preparing steroid esters compound |
| 07/29/1998 | CN1039318C 3,3-dithiobis dipropyl acid and prepration method of esters thereof |
| 07/28/1998 | US5786465 Secreted proteins and polynucleotides encoding them |
| 07/28/1998 | US5786379 Adamantyl-substituted biaromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 07/28/1998 | US5786360 Antiallergens, central nervous system stimulants, diuretics, antihistamines, cardiotonic agents; water solubility |
| 07/28/1998 | US5786347 Vitamin D amine and amide derivatives |
| 07/28/1998 | US5786159 Method of producing antibodies to a restricted population of T lymphocytes antibodies produced therefrom and methods of use thereof |
| 07/28/1998 | CA2227978A1 Immune-modulation with amino acids |
| 07/28/1998 | CA2220851A1 Cdna clone he8ch90 that encodes a novel 7-transmembrane receptor |
| 07/23/1998 | WO1998031802A2 Secreted proteins and polynucleotides encoding them |
| 07/23/1998 | WO1998031796A1 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/23/1998 | WO1998031795A2 Novel human metallothionein |
| 07/23/1998 | WO1998031674A1 Phthalazinones |
| 07/23/1998 | WO1998031393A2 Polysaccharide-peptide-conjugates |
| 07/23/1998 | WO1998031364A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
| 07/23/1998 | WO1998031343A2 Aqueous suspension for nasal administration of loteprednol |
| 07/23/1998 | WO1998031227A1 Novel cannabinoid receptor modulators |
| 07/23/1998 | CA2278596A1 Novel human metallothionein |
| 07/23/1998 | CA2278309A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
| 07/23/1998 | CA2278307A1 Novel cannabinoid receptor modulators |
| 07/23/1998 | CA2278153A1 Secreted proteins and polynucleotides encoding them |
| 07/23/1998 | CA2276111A1 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/22/1998 | EP0854188A2 Streptococcus pneumoniae aroE polypeptides and polynucleotides |
| 07/22/1998 | EP0854187A2 Novel glucose 6-phosphate dehydrogenase gene |
| 07/22/1998 | EP0854186A2 Staphylococcus aureus cell division gene DivIB |
| 07/22/1998 | EP0853943A1 Antiallergic agent |
| 07/22/1998 | EP0853665A2 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 07/22/1998 | EP0853661A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 07/22/1998 | EP0853629A1 Hepadnavirus receptor |
| 07/22/1998 | EP0853614A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors |
| 07/22/1998 | EP0853486A2 Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases |
| 07/22/1998 | EP0748312B1 Bicyclic carbamates as leukotriene d4 antagonists |
| 07/22/1998 | CN1188483A Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseases |
| 07/22/1998 | CN1188412A Means for treating radiation injuries |
| 07/21/1998 | US5783602 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents |
| 07/21/1998 | US5783594 Administering to treat glioma, colon cancer and immunological disordaers |
| 07/21/1998 | US5783569 An immunostimulant which does not cause fever or inflammation, derived from yeast, wound healing |
| 07/21/1998 | US5783216 Adjustment, removal or masking antigen |
| 07/21/1998 | US5783193 Therapeutic antigens microencapsulated in water based protective enteric coating which is completely free of organic solvents |
| 07/21/1998 | US5783184 Administering monoclonal antibodies |
| 07/21/1998 | CA2220850A1 Novel aroe |
| 07/21/1998 | CA2011874C Sdk peptides, a preparation process of the same and therapeutic compositions containing them |
| 07/21/1998 | CA1339964C Substituted adenine derivatives useful as therapeutic agents |
| 07/21/1998 | CA1339958C Isoferritin as a marker for pathological pregnancy |
| 07/16/1998 | WO1998030706A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 07/16/1998 | WO1998030696A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030693A2 Tumor necrosis factor receptor 5 |
| 07/16/1998 | WO1998030589A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030586A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 07/16/1998 | WO1998030584A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030582A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030581A1 Myelopeptides and their therapeutic use |
| 07/16/1998 | WO1998030241A1 Methods of therapeutic administration of anti-cd40l compounds |